Pfenex
San Diego
About Pfenex
Headquartered in San Diego, California, PfÄ“nex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, PfÄ“nex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. PfÄ“nex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $63.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2018)
- Ticker: nyse:PFNX
- Website: pfenex.com
- Phone: 18583524339
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pfenex-171658 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.